PRAGUE-26 trial: Catheter-directed thrombolysis cuts pulmonary embolism complications

PRAGUE-26 trial found catheter-directed thrombolysis reduced the primary endpoint from 6.8% to 0.7% versus anticoagulation alone in intermediate-high-risk pulmonary embolism.

Carried by 3 publishers across 3 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.